Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Biofouling ; 29(6): 651-60, 2013.
Article in English | MEDLINE | ID: mdl-23731460

ABSTRACT

Biofilms confer protection from adverse environmental conditions and can be reservoirs for pathogenic organisms and sources of disease outbreaks, especially in medical devices. The goal of this research was to evaluate the anti-biofilm activities of silver nanoparticles (AgNPs) against several microorganisms of clinical interest. The antimicrobial activity of AgNPs was tested within biofilms generated under static conditions and also under high fluid shears conditions using a bioreactor. A 4-log reduction in the number of colony-forming units of Pseudomonas aeruginosa was recorded under turbulent fluid conditions in the CDC reactor on exposure to 100 mg ml(-1) of AgNPs. The antibacterial activity of AgNPs on various microbial strains grown on polycarbonate membranes is reported. In conclusion, AgNPs effectively prevent the formation of biofilms and kill bacteria in established biofilms, which suggests that AgNPs could be used for prevention and treatment of biofilm-related infections. Further research and development are necessary to translate this technology into therapeutic and preventive strategies.


Subject(s)
Biofilms/drug effects , Bioreactors/microbiology , Metal Nanoparticles , Pseudomonas aeruginosa/drug effects , Silver/pharmacology , Biofilms/growth & development , Colony Count, Microbial , Metal Nanoparticles/chemistry , Microscopy, Confocal , Microscopy, Electron, Transmission , Particle Size , Polymers/chemistry , Pseudomonas aeruginosa/growth & development , Silver/chemistry , Spectrophotometry, Ultraviolet , Surface Properties
2.
Nanomedicine ; 8(3): 328-36, 2012 Apr.
Article in English | MEDLINE | ID: mdl-21718674

ABSTRACT

The incorporation of nanoparticles (NPs) in industrial and biomedical applications has increased significantly in recent years, yet their hazardous and toxic effects have not been studied extensively. Here, we studied the effects of 24 nm silver NPs (AgNPs) on a panel of bacteria isolated from medical devices used in a hospital intensive care unit. The cytotoxic effects were evaluated in macrophages and the expression of the inflammatory cytokines IL-6, IL-10 and TNF-α were quantified. The effects of NPs on coagulation were tested in vitro in plasma-based assays. We demonstrated that 24 nm AgNPs were effective in suppressing the growth of clinically relevant bacteria with moderate to high levels of antibiotic resistance. The NPs had a moderate inhibitory effect when coagulation was initiated through the intrinsic pathway. However, these NPs are cytotoxic to macrophages and are able to elicit an inflammatory response. Thus, beneficial and potential harmful effects of 24 nm AgNPs on biomedical devices must be weighed in further studies in vivo. From the Clinical Editor: The authors of this study demonstrate that gallic acid reduced 24 nm Ag NPs are effective in suppressing growth of clinically relevant antibiotic resistant bacteria. However, these NPs also exhibit cytotoxic properties to macrophages and may trigger an inflammatory response. Thus, the balance of beneficial and potential harmful effects must be weighed carefully in further studies.


Subject(s)
Anti-Bacterial Agents/pharmacology , Blood Coagulation/drug effects , Inflammation/pathology , Metal Nanoparticles/toxicity , Silver/pharmacology , Silver/toxicity , Bacteria/drug effects , Cell Death/drug effects , Cell Line , Cytokines/metabolism , Humans , Inflammation Mediators/metabolism , Light , Macrophages/cytology , Macrophages/drug effects , Metal Nanoparticles/ultrastructure , Microbial Sensitivity Tests , Particle Size , Scattering, Radiation
3.
Nanomedicine ; 6(5): 681-8, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20215045

ABSTRACT

Microbial resistance represents a challenge for the scientific community to develop new bioactive compounds. Nosocomial infections represent an enormous emerging problem, especially in patients with ambulatory treatment, which requires that they wear medical devices for an extended period of time. In this work, an evaluation of the antimicrobial activity of both silver and titanium nanoparticles was carried out against a panel of selected pathogenic and opportunistic microorganisms, some of them commonly associated with device-associated infections. Cytotoxicity assays monitoring DNA damage and cell viability were evaluated using human-derived monocyte cell lines. We show that silver-coated nanoparticles having a size of 20-25 nm were the most effective among all the nanoparticles assayed against the tested microorganisms. In addition, these nanoparticles showed no significant cytotoxicity, suggesting their use as antimicrobial additives in the process of fabrication of ambulatory and nonambulatory medical devices. FROM THE CLINICAL EDITOR: In this study, antimicrobial activity of silver and titanium nanoparticles was evaluated against a panel of selected pathogenic and opportunistic microorganisms. Silver-coated nanoparticles of 20-25 nm size were the most effective among all the nanoparticles without significant cytotoxicity, suggesting their use as antimicrobial additives in the process of fabrication of ambulatory and nonambulatory medical devices.


Subject(s)
Anti-Infective Agents/pharmacology , Metal Nanoparticles/chemistry , Silver/chemistry , Titanium/chemistry , Anti-Infective Agents/adverse effects , Anti-Infective Agents/chemical synthesis , Anti-Infective Agents/chemistry , Bacteria/drug effects , Bacteria/genetics , Cell Line , DNA Damage/drug effects , Fungi/drug effects , Fungi/genetics , Humans , Metal Nanoparticles/adverse effects , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...